You
← Back to results
HB
Hoverink Biotechnologies, Inc.Company · Health · CA
RealCurrent
Mission statement · Company scope

“Our mission is to improve the lives of patients who suffer from rare diseases for which there are limited or no available treatments, with an initial therapeutic focus on Cirrhosis ascites, patients suffering from AIDS, Cancer and chronic pain, nausea and discomfort associated with chemotherapy and neuropathy.”

MissionImpactLeads with changeMission-drivenClimate & health
✎ Write one like this
In use2017 – now1 sighting
First seenNov 2017Added
Last seenNov 2017Latest observation
Date created—Not published by the organization
Record
Kind
Mission
Scope
Company
Style
Impact (primary) · Problem–solution
Leads with
Change
Best for
Mission-driven · Climate & health
Formula
A world where [change]
Tone
Aspirational
Length
47 words · reading grade 24.6
Review status
unreviewed · classifier rules-v0
Quality score
0.60
Record
st_98d0dc68b946ce97
Classification confidence
0.71
Sources1 sighting
SEC
SEC EDGAR filingsObserved 2017-11-06 · sec_sentence · 10-K · accession 0001437749-17-018399
View filing ↗
Report an issueReports are reviewed within 3 working days.
0 to compareCompare